Add Company
Join Now

BellBrook Labs Revenue and Competitors

License our Company Data API

Madison, WI USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BellBrook Labs's estimated annual revenue is currently $3.4M per year.(i)
  • BellBrook Labs's estimated revenue per employee is $155,000

Employee Data

  • BellBrook Labs has 22 Employees.(i)
  • BellBrook Labs grew their employee count by 5% last year.

BellBrook Labs's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Senior ScientistReveal Email/Phone
5
Senior ScientistReveal Email/Phone
6
Associate ScientistReveal Email/Phone
7
Senior Scientist, Assay DevelopmentReveal Email/Phone
8
Senior Scientist, Discovery ServicesReveal Email/Phone
9
Marketing Coordinator IReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.8M1820%N/AN/A
#2
$1.9M1233%N/AN/A
#3
$1.1M70%N/AN/A
#4
$0.9M60%N/AN/A
#5
$5.2M670%$45.5MN/A
#6
$1.4M90%N/AN/A
#7
$1.6M100%N/AN/A
#8
$1.1M717%N/AN/A
#9
$13.5M87-17%N/AN/A
#10
$0.6M4-20%N/AN/A
Add Company

What Is BellBrook Labs?

BellBrook Labs is dedicated to providing the pharmaceutical industry with enabling screening tools to accelerate the discovery of more effective therapies. As a small, R&D-driven company, we identify areas where there is a strong need but a significant technical hurdle, and then we develop a solution. Transcreener® Biochemical Assay Technology: Our proprietary Transcreener® HTS Platform was developed to move more new targets into HTS more rapidly, and to streamline selectivity profiling within a target family. It relies on homogenous fluorescent immunodetection of nucleotides, including ADP, UDP, GDP, AMP and GMP, that are formed by thousands of cellular enzymes. Among these are group transferase families, such as kinases and glycosyltransferases, that catalyze the covalent regulatory reactions that are central to cell signaling. Each Transcreener Assay provides a generic detection method for multiple enzyme families. This means that you can focus on evaluating new therapeutic strategies and optimizing lead molecules rather than on time-consuming assay development for individual targets. The platform has been rapidly validated and adopted by pharmaceutical and biotechnology screening labs around the world.

keywords:N/A

N/A

Total Funding

22

Number of Employees

$3.4M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.2M220%N/A
#2
$2.2M225%N/A
#3
$4.2M22-35%N/A
#4
$2.2M22N/AN/A
#5
$2.2M220%N/A